Carol is the “go-to” person for many multinationals on U.S. legal matters related to internal investigations, government investigations, and commercial litigations. She regularly represents clients before key U.S. agencies, including the Securities and Exchange Commission (SEC), the Department of Justice (DOJ), the Bureau of Industry and Security (BIS) of the Department of Commerce, the Office of Foreign Assets Control (OFAC) of the Department of the Treasury, and U.S. Customs and Border Protection (CBP). She has a proven track record of defending clients in matters involving sensitive corporate governance and regulatory issues.
Carol is recognized in the legal community for her vast experience in cross-border litigation and investigation issues, as well as her in-depth understanding of the nuances of conflicts of law and their implications in practice. She is battle-tested in all stages of government investigations and high-stakes commercial litigations. She is highly experienced in handling sensitive documents in cross-border matters, including guiding a China-based company through a Department of Justice (DOJ) investigation stemming from patent litigation, where she adeptly managed discovery disputes to safeguard her client’s interests.
Carol’s expertise spans U.S. export controls, economic sanctions, Committee on Foreign Investment in the United States (CFIUS) reviews, anti-money laundering (AML) compliance, Foreign Corrupt Practices Act (FCPA) regulations, data security, forced labor, consumer protection, and intellectual property disputes. She excels in resolving complex regulatory challenges for companies operating across diverse industries, from financial services and technology to manufacturing and pharmaceuticals. Her ability to coordinate and integrate multidisciplinary resources—working closely with government regulatory and enforcement teams—enables her to craft comprehensive, tailored strategies that address broader business concerns while limiting the scope of discovery in litigation and investigations.
Carol is also familiar with U.S. regulatory issues in cross-border transactions, having assisted with due diligence and remediation in numerous initial public offerings (IPOs) and mergers and acquisitions (M&A).
Representative Experience
Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.
- Represented a major global telecommunications company in connection with a historic multi-year U.S. export control enforcement action and post-settlement monitorship; obtained first-ever temporary general license to allow company to operate while under investigation
- Represented multiple leading global logistics companies on U.S. economic sanctions compliance matters, managed disclosures to the U.S. Department of Treasury, and prepared responses to subpoenas and requests from relevant U.S. regulatory agencies
- Conducted anti-bribery diligence for leading international medical equipment firm in support of its acquisition of a Chinese medical equipment distributor
- Provided FCPA compliance advice in connection with exiting a joint venture in China for a leading U.S. pharmaceutical company
- Provided sanctions and export controls advice for US operations of German logistics company
- Represented a major U.S. aerospace company in connection with a global FCPA internal investigation and related disclosures to the U.S. government
Thought Leadership
- Speaker, “International Anti-Money Laundering Trends: U.S. Regulatory Developments,” Thomson Reuters Greater China AML Trends Webinar, May 13, 2022
- Co-Author, “Whistleblowing in China: Demystifying the Myths,” Regulatory Investigations and Financial Crime Insights Blog (Clifford Chance), April 8, 2022
- Contributor, “The Latest Download on Apps: New Risks for Companies Operating in Both the US and China,” Client Alert (Clifford Chance), June 25, 2021
- Contributor, “US Export Controls Need to Be Part of Your Pre-Flight Checklist for Commercial Aircraft Transfers,” Client Alert (Clifford Chance), June 3, 2021
Languages
- Mandarin
- Taiwanese
- Japanese